Collectively, these results confirmed that IPO13 has multiple roles in tumorigenesis of NSCLC, which upregulates hTERT expression by mediating RFPL3 translocation from the cytoplasm to the nucleus, and further induces its binding at hTERT promoter. This evidence concerns the gene IPO13 and non-small cell lung carcinoma.